Vaccination against H5 avian influenza virus induces long-term humoral immune responses in flamingoes (Phoenicopterus spp.)

被引:2
|
作者
Fernandez-Bellon, Hugo [1 ,2 ]
Vergara-Alert, Julia [3 ]
Almagro, Vanessa [1 ,2 ]
Rivas, Raquel [3 ]
Sanchez, Azucena [4 ]
Carmen Martinez, Maria [4 ]
Majo, Natalia [2 ,3 ]
Busquets, Nuria [3 ]
Ramis, Antonio [2 ,3 ]
机构
[1] Parc Zool Barcelona, Parc Ciutadella S-N, Barcelona 08003, Spain
[2] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain
[3] CReSA, IRTA, Campus Univ Autonoma Barcelona, Barcelona 08193, Spain
[4] Lab Cent Vet, Serv Virol, Ctra Algete,Km 8, Madrid 28110, Spain
关键词
Avian influenza; Zoo birds; Flamingo; Vaccination; Long-term immunity; H5N1; ZOO-BIRDS; HONG-KONG;
D O I
10.1016/j.vaccine.2016.04.078
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Avian influenza (AI) can represent a threat to endangered wild birds, as demonstrated with the H5N1 highly pathogenic AI (HPAI) outbreaks. Vaccination against AI using inactivated H5-vaccines has been shown to induce humoral immune response in zoo bird species. In this study, the long-term efficacy of H5-vaccination was evaluated in flamingoes from Barcelona Zoo. Specific H5-antibody titres were maintained at high levels (geometric mean titres >= 32) for over 7 years after vaccination, both against the H5N9 and H5N3 vaccine strains, as well as H5N3 and H5N1 reference strains. In addition the breadth of the immune response was also studied by testing antibody production against H1-, H3-, H4-, H7-, and H10 subtypes. It was observed that most flamingoes presented specific antibodies against H1 virus subtypes, but titres to the other HA-subtypes were rarely detected. We show that AI-vaccines can induce immunity lasting seven years in flamingoes, which suggests that vaccination can provide long term protection from HPAI outbreaks in zoo birds. (C) 2016 Published by Elsevier Ltd.
引用
收藏
页码:3082 / 3086
页数:5
相关论文
共 50 条
  • [41] Discrepancies in the efficacy of H5 inactivated avian influenza vaccines in specific-pathogen-free chickens against challenge with the Egyptian H5N8 clade 2.3.4.4 Group B virus isolated in 2018
    Abd El-Moeid, Amena
    Hany, Ayman
    Elsaied, Marwa Fathy
    Soliman, Reem Ahamed
    Mohamed, Mounir
    Hussein, Hussein Aly
    VETERINARY WORLD, 2021, 14 (08) : 2131 - 2141
  • [42] Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies
    de la Maza, Susana Sainz
    Walo-Delgado, Paulette Esperanza
    Rodriguez-Dominguez, Mario
    Monreal, Enric
    Rodero-Romero, Alexander
    Chico-Garcia, Juan Luis
    Pariente, Roberto
    Rodriguez-Jorge, Fernando
    Ballester-Gonzalez, Ruben
    Villarrubia, Noelia
    Romero-Hernandez, Beatriz
    Masjuan, Jaime
    Costa-Frossard, Lucienne
    Villar, Luisa Maria
    VACCINES, 2023, 11 (04)
  • [43] Immunization with the H5N1 Recombinant Vaccine Candidate Induces High Protection in Chickens against Vietnamese Highly Pathogenic Avian Influenza Virus Strains
    Hang Thi Thu Hoang
    Chi Hung Nguyen
    Ngan Thi Thuy Nguyen
    An Dang Pham
    Hang Thi Thu Nguyen
    Thanh Hoa Le
    Hanh Xuan Tran
    Ha Hoang Chu
    Nam Trung Nguyen
    VACCINES, 2020, 8 (02)
  • [44] Codon optimization of antigen coding sequences improves the immune potential of DNA vaccines against avian influenza virus H5N1 in mice and chickens
    Stachyra, Anna
    Redkiewicz, Patrycja
    Kosson, Piotr
    Protasiuk, Anna
    Gora-Sochacka, Anna
    Kudla, Grzegorz
    Sirko, Agnieszka
    VIROLOGY JOURNAL, 2016, 13
  • [45] Long-term vaccine-induced heterologous protection against H5N1 influenza viruses in the ferret model
    Ducatez, Mariette F.
    Webb, Ashley
    Crumpton, Jeri-Carol
    Webby, Richard J.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (04) : 506 - 512
  • [46] Microneedle Delivery of H5N1 Influenza Virus-Like Particles to the Skin Induces Long-Lasting B- and T-Cell Responses in Mice
    Song, Jae-Min
    Kim, Yeu-Chun
    Lipatov, Aleksandr S.
    Pearton, Marc
    Davis, C. Todd
    Yoo, Dae-Goon
    Park, Kyoung-Mi
    Chen, Li-Mei
    Quan, Fu-Shi
    Birchall, James C.
    Donis, Ruben O.
    Prausnitz, Mark R.
    Compans, Richard W.
    Kang, Sang-Moo
    CLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (09) : 1381 - 1389
  • [47] Multiple dose vaccination with heterologous H5N2 vaccine: Immune response and protection against variant clade 2.2.1 highly pathogenic avian influenza H5N1 in broiler breeder chickens
    Abdelwhab, E. M.
    Grund, Christian
    Aly, Mona M.
    Beer, Martin
    Harder, Timm C.
    Hafez, Hafez M.
    VACCINE, 2011, 29 (37) : 6219 - 6225
  • [48] Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks
    Kim, Deok-Hwan
    Lee, Seung-hun
    Kim, Jiwon
    Lee, Jiho
    Jeong, Jei-hyun
    Kim, Ji-yun
    Song, Seung-un
    Lee, Hyukchae
    Cho, Andrew Y.
    Hyeon, Ji-Yeon
    Youk, Sungsu
    Song, Chang-Seon
    VACCINE, 2024, 42 (18) : 3756 - 3767
  • [49] Heterologous post-infection immunity against Egyptian avian influenza virus (AIV) H9N2 modulates the course of subsequent infection by highly pathogenic AIV H5N1, but vaccination immunity does not
    Naguib, Mahmoud M.
    Grund, Christian
    Arafa, Abdel-Satar
    Abdelwhab, E. M.
    Beer, Martin
    Harder, Timm C.
    JOURNAL OF GENERAL VIROLOGY, 2017, 98 (06) : 1169 - 1173
  • [50] Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses
    Bertran, Kateri
    Kassa, Aemro
    Criado, Miria F.
    Nunez, Ivette A.
    Lee, Dong-Hun
    Killmaster, Lindsay
    Silva, Mariana Sa e
    Ross, Ted M.
    Mebatsion, Teshome
    Pritchard, Nikki
    Swayne, David E.
    VACCINE, 2021, 39 (14) : 1933 - 1942